Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

$1.75

-$0.11 (-5.91%)

At close: Oct 30, 2026, 4:00 PM ET

$1.85

+$0.10 (+5.71%)

After-hours: Oct 30, 2026, 7:31 PM ET

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-7.82M	-4.35M	-3.78M
Interest Income	n/a	n/a	n/a
Pretax Income	-8.99M	-30.36M	-3.78M
Net Income	-8.99M	-30.36M	-3.78M
Selling & General & Admin	1.56M	1.54M	1.01M
Research & Development	6.27M	2.81M	2.77M
Other Expenses	n/a	n/a	n/a
Operating Expenses	7.82M	4.35M	3.78M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	7.82M	4.35M	3.78M
Income Tax Expense	n/a	n/a	n/a
Shares Outstanding (Basic)	47.34M	189.37M	189.37M
Shares Outstanding (Diluted)	47.34M	189.37M	189.37M
EPS (Basic)	-0.19	-0.16	-0.02
EPS (Diluted)	-0.19	-0.16	-0.02
EBITDA	-8.99M	-30.36M	-3.78M
EBIT	-8.99M	-30.36M	-3.78M
Depreciation & Amortization	n/a	n/a	n/a